Cargando…

Emerging Nano‐/Microapproaches for Cancer Immunotherapy

Cancer immunotherapy has achieved remarkable clinical efficacy through recent advances such as chimeric antigen receptor‐T cell (CAR‐T) therapy, immune checkpoint blockade (ICB) therapy, and neoantigen vaccines. However, application of immunotherapy in a clinical setting has been limited by low dura...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Yu, Hagan, C. Tilden, Vincent, Benjamin G., Wang, Andrew Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425500/
https://www.ncbi.nlm.nih.gov/pubmed/30937265
http://dx.doi.org/10.1002/advs.201801847
_version_ 1783404852018151424
author Mi, Yu
Hagan, C. Tilden
Vincent, Benjamin G.
Wang, Andrew Z.
author_facet Mi, Yu
Hagan, C. Tilden
Vincent, Benjamin G.
Wang, Andrew Z.
author_sort Mi, Yu
collection PubMed
description Cancer immunotherapy has achieved remarkable clinical efficacy through recent advances such as chimeric antigen receptor‐T cell (CAR‐T) therapy, immune checkpoint blockade (ICB) therapy, and neoantigen vaccines. However, application of immunotherapy in a clinical setting has been limited by low durable response rates and immune‐related adverse events. The rapid development of nano‐/microtechnologies in the past decade provides potential strategies to improve cancer immunotherapy. Advances of nano‐/microparticles such as virus‐like size, high surface to volume ratio, and modifiable surfaces for precise targeting of specific cell types can be exploited in the design of cancer vaccines and delivery of immunomodulators. Here, the emerging nano‐/microapproaches in the field of cancer vaccines, immune checkpoint blockade, and adoptive or indirect immunotherapies are summarized. How nano‐/microparticles improve the efficacy of these therapies, relevant immunological mechanisms, and how nano‐/microparticle methods are able to accelerate the clinical translation of cancer immunotherapy are explored.
format Online
Article
Text
id pubmed-6425500
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64255002019-04-01 Emerging Nano‐/Microapproaches for Cancer Immunotherapy Mi, Yu Hagan, C. Tilden Vincent, Benjamin G. Wang, Andrew Z. Adv Sci (Weinh) Reviews Cancer immunotherapy has achieved remarkable clinical efficacy through recent advances such as chimeric antigen receptor‐T cell (CAR‐T) therapy, immune checkpoint blockade (ICB) therapy, and neoantigen vaccines. However, application of immunotherapy in a clinical setting has been limited by low durable response rates and immune‐related adverse events. The rapid development of nano‐/microtechnologies in the past decade provides potential strategies to improve cancer immunotherapy. Advances of nano‐/microparticles such as virus‐like size, high surface to volume ratio, and modifiable surfaces for precise targeting of specific cell types can be exploited in the design of cancer vaccines and delivery of immunomodulators. Here, the emerging nano‐/microapproaches in the field of cancer vaccines, immune checkpoint blockade, and adoptive or indirect immunotherapies are summarized. How nano‐/microparticles improve the efficacy of these therapies, relevant immunological mechanisms, and how nano‐/microparticle methods are able to accelerate the clinical translation of cancer immunotherapy are explored. John Wiley and Sons Inc. 2019-01-13 /pmc/articles/PMC6425500/ /pubmed/30937265 http://dx.doi.org/10.1002/advs.201801847 Text en © 2019 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Mi, Yu
Hagan, C. Tilden
Vincent, Benjamin G.
Wang, Andrew Z.
Emerging Nano‐/Microapproaches for Cancer Immunotherapy
title Emerging Nano‐/Microapproaches for Cancer Immunotherapy
title_full Emerging Nano‐/Microapproaches for Cancer Immunotherapy
title_fullStr Emerging Nano‐/Microapproaches for Cancer Immunotherapy
title_full_unstemmed Emerging Nano‐/Microapproaches for Cancer Immunotherapy
title_short Emerging Nano‐/Microapproaches for Cancer Immunotherapy
title_sort emerging nano‐/microapproaches for cancer immunotherapy
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425500/
https://www.ncbi.nlm.nih.gov/pubmed/30937265
http://dx.doi.org/10.1002/advs.201801847
work_keys_str_mv AT miyu emergingnanomicroapproachesforcancerimmunotherapy
AT haganctilden emergingnanomicroapproachesforcancerimmunotherapy
AT vincentbenjaming emergingnanomicroapproachesforcancerimmunotherapy
AT wangandrewz emergingnanomicroapproachesforcancerimmunotherapy